The present study focused on the investigation of HMGB1‐induced tumor metastasis and regulated RSF1‐IT2, hoping to further clarify the signaling pathway of HMGB1 and provide novel therapeutic target for the treatment of NSCLC. This evidence concerns the gene HMGB1 and neoplasm.